| Pulmonary innate lymphoid cells are major producers of IL‐5 and IL‐13 in murine models of allergic asthma RGJK Wolterink, A KleinJan, M van Nimwegen, I Bergen, M de Bruijn, ... European journal of immunology 42 (5), 1106-1116, 2012 | 583 | 2012 |
| Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy Y Gong, RGJ Klein Wolterink, J Wang, GMJ Bos, WTV Germeraad Journal of hematology & oncology 14 (1), 73, 2021 | 257 | 2021 |
| Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells RGJ Klein Wolterink, N Serafini, M van Nimwegen, CAJ Vosshenrich, ... Proceedings of the National Academy of Sciences 110 (25), 10240-10245, 2013 | 256 | 2013 |
| Gata3 drives development of RORγt+ group 3 innate lymphoid cells N Serafini, RGJ Klein Wolterink, N Satoh-Takayama, W Xu, ... Journal of Experimental Medicine 211 (2), 199-208, 2014 | 236 | 2014 |
| Influence of vitamin C on lymphocytes: an overview GNY Van Gorkom, RGJ Klein Wolterink, CHMJ Van Elssen, L Wieten, ... Antioxidants 7 (3), 41, 2018 | 192 | 2018 |
| BTK signaling in B cell differentiation and autoimmunity OBJ Corneth, RGJ Klein Wolterink, RW Hendriks B Cell Receptor Signaling, 67-105, 2015 | 155 | 2015 |
| GATA-3 promotes T-cell specification by repressing B-cell potential in pro–T cells in mice ME García-Ojeda, RGJ Klein Wolterink, F Lemaître, O Richard-Le Goff, ... Blood, The Journal of the American Society of Hematology 121 (10), 1749-1759, 2013 | 125 | 2013 |
| Neuro-mesenchymal units control ILC2 and obesity via a brain–adipose circuit F Cardoso, RGJ Klein Wolterink, C Godinho-Silva, RG Domingues, ... Nature 597 (7876), 410-414, 2021 | 95 | 2021 |
| Neuroimmune interactions in peripheral organs RGJ Klein Wolterink, GS Wu, IM Chiu, H Veiga-Fernandes Annual review of neuroscience 45 (1), 339-360, 2022 | 79 | 2022 |
| Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice A KleinJan, RGJ Klein Wolterink, Y Levani, MJW de Bruijn, ... The Journal of Immunology 192 (4), 1385-1394, 2014 | 66 | 2014 |
| Absence of interleukin‐17 receptor a signaling prevents autoimmune inflammation of the joint and leads to a Th2‐like phenotype in collagen‐induced arthritis OBJ Corneth, AMC Mus, PS Asmawidjaja, RGJ Klein Wolterink, ... Arthritis & Rheumatology 66 (2), 340-349, 2014 | 58 | 2014 |
| The intrathymic crossroads of T and NK cell differentiation RGJ Klein Wolterink, ME García‐Ojeda, CAJ Vosshenrich, RW Hendriks, ... Immunological reviews 238 (1), 126-137, 2010 | 46 | 2010 |
| Type 2 innate lymphocytes in allergic airway inflammation RGJ Klein Wolterink, RW Hendriks Current allergy and asthma reports 13, 271-280, 2013 | 45 | 2013 |
| Rosuvastatin enhances VSV-G lentiviral transduction of NK cells via upregulation of the low-density lipoprotein receptor Y Gong, RGJK Wolterink, I Janssen, AJ Groot, GMJ Bos, WTV Germeraad Molecular Therapy-Methods & Clinical Development 17, 634-646, 2020 | 43 | 2020 |
| Defucosylation of tumor-specific humanized anti-MUC1 monoclonal antibody enhances NK cell-mediated anti-tumor cell cytotoxicity Y Gong, RGJ Klein Wolterink, V Gulaia, S Cloosen, FAI Ehlers, L Wieten, ... Cancers 13 (11), 2579, 2021 | 16 | 2021 |
| Neuroendocrine cells take your breath away RGJK Wolterink, RM Pirzgalska, H Veiga-Fernandes Immunity 49 (1), 9-11, 2018 | 15 | 2018 |
| NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody Y Gong, WTV Germeraad, X Zhang, N Wu, B Li, L Janssen, Z He, ... Molecular Therapy 32 (8), 2711-2727, 2024 | 4 | 2024 |
| Cellulaire immunotherapie G van Gorkom, RGJ Klein Wolterink, WTV Germeraad Bijblijven 34, 149-159, 2018 | | 2018 |
| ILC2 in Immunity R Klein Wolterink | | 2016 |
| ILC2 in Immunity RGJK Wolterink Academic Press, 2016 | | 2016 |
